Top compounds associated with response to SPRR4


Feature Type Standardized
Nominal ANOVA
mRNA DMOG GDSC1000 pan-cancer AAC -0.083 0.01
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.084 0.02
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.12 0.02
mRNA tivozanib GDSC1000 pan-cancer AAC 0.081 0.02
mRNA Topotecan CCLE pan-cancer AAC -0.099 0.02
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.08 0.02
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.072 0.02
mRNA Crizotinib gCSI pan-cancer AAC -0.13 0.02
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.079 0.03
mRNA MP470 GDSC1000 pan-cancer AAC 0.074 0.03
Download CSV